Amazon eyes potential US$100m investment in India's Apollo Pharmacy: ET
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[BENGALURU] Amazon.com Inc is considering a nearly US$100 million investment in India's pharmacy chain Apollo Pharmacy, facing up to Reliance Industries and Tata Group in the country's fast-growing drug market, the Economic Times reported on Wednesday, citing two people aware of the plans.
Amazon already delivers medicines in India and the potential investment would come amid rising competition from Mukesh Ambani's Reliance, which bought a majority stake in online pharmacy Netmeds.
Tata Group, meanwhile, was reportedly in talks to pick up a majority stake in e-pharmacy firm 1mg.
Both Amazon and Apollo Hospitals, which owns Apollo Pharmacy, did not immediately respond to Reuters request for comments.
The growth of e-pharmacies, however, has left many Indian trader groups feeling threatened, who say online drugstores can contribute to medicine sales without proper verification and the entry of large players can cause unemployment in the sector.
Amazon's plan to further expand in India also comes close on the heels of its launch of an online pharmacy to deliver prescription drugs in the United States, increasing competition with drug retailers such as Walgreens, CVS Health and Walmart.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium
